Biallelic mutations in another ceramide synthase (CERS1), which catalyzes the formation of C18 ceramides and is highly expressed in the brain, causes a novel progressive myoclonic epilepsy associated with neurodegeneration (17). The gene discussed is CERS1; the disease is myoclonic epilepsy.